Detalles de la búsqueda
1.
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
N Engl J Med
; 371(2): 107-18, 2014 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24881463
2.
Metabolomics biomarkers of frailty in elderly breast cancer patients.
J Cell Physiol
; 229(7): 898-902, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24659054
3.
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.
BMC Cancer
; 14: 954, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25512030
4.
Epirubicin and docetaxel as neoadjuvant treatment of hormone receptor positive, HER-2 negative breast cancer: findings from two successive phase II studies.
Radiol Oncol
; 47(1): 57-62, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23450278
5.
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Breast Cancer Res
; 13(6): R117, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22112244
6.
Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer.
Breast Cancer Res Treat
; 123(1): 303-10, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20195744
7.
Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study.
BMC Cancer
; 10: 205, 2010 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-20470379
8.
Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study.
Tumori
; 96(2): 229-33, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20572578
9.
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.
Breast Cancer Res Treat
; 113(1): 137-44, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18259856
10.
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
Breast Cancer Res Treat
; 116(3): 491-500, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18953651
11.
Trastuzumab and vinorelbine as highly effective and safe therapy for HER-2-overexpressing metastatic breast cancer. A single institution experience.
Tumori
; 94(4): 464-8, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18822679
12.
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.
J Clin Oncol
; 23(28): 7089-97, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16192592
13.
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience.
J Clin Oncol
; 23(7): 1390-400, 2005 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15735115
14.
Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.
Oncotarget
; 7(26): 39809-39822, 2016 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27223427
15.
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
J Clin Oncol
; 21(24): 4517-23, 2003 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14673038
16.
Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.
BMC Cancer
; 5: 70, 2005 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-15996267
17.
New oral drugs in older patients: a review of idarubicin in elderly patients.
Crit Rev Oncol Hematol
; 49(2): 153-63, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15012975
18.
Adjuvant therapy in elderly patients with breast cancer.
Clin Breast Cancer
; 5(3): 188-95; discussion 196-7, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15335450
19.
Special populations: elderly patients.
Cancer Treat Res
; 151: 299-315, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19593520
20.
Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?
Tumori
; 95(1): 130; author reply 131, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19366074